EQS-News: Abivax announces the pricing of its Initial Public Offering on the Nasdaq Global Market
EQS-News: ABIVAX / Key word(s): IPO Abivax announces the pricing of its Initial Public Offering on the Nasdaq Global Market&...
Stay updated with breaking news from Securities Note. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: ABIVAX / Key word(s): IPO Abivax announces the pricing of its Initial Public Offering on the Nasdaq Global Market&...
Abivax Announces Trading Resumption of its Ordinary Shares on Euronext ...
PARIS, FRANCE / ACCESSWIRE / October 20, 2023 / Abivax SA (PARIS:FR) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's
PARIS, FRANCE / ACCESSWIRE / October 18, 2023 / Abivax SA (PARIS:FR) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's
EQS-News: ABIVAX / Key word(s): IPOAbivax announces the filing of an amended registration statement, including an estimated initial public offering price range 19.10.2023 / 00:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax announces the filing of an amended registration state...